Ignite Creation Date:
2025-12-26 @ 10:45 PM
Ignite Modification Date:
2026-01-17 @ 7:43 PM
Study NCT ID:
NCT04870112
Status:
TERMINATED
Last Update Posted:
2025-04-17
First Post:
2021-04-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate Subcutaneous Durvalumab in Patients With Non-Small Cell Lung Cancer and Small Cell Lung Cancer
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-28
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-08-30
Completion Date Type:
ACTUAL
First Submit Date:
2021-04-16
First Submit QC Date:
None
Study First Post Date:
2021-05-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-15
Last Update Post Date:
2025-04-17
Last Update Post Date Type:
ACTUAL